Abstract
Hyperlipidemia is a worsening health condition in developed and developing countries, especially among the younger generation due to their lifestyle. The World Health Organization reported 2.6 million deaths globally due to hyperlipidemia. Therefore, there is a huge demand of antihyperlipidemic drugs in the pharmaceutical market. Approximately 60% of the total active drug content used in hyperlipidemia suffer from poor water solubility, particularly BCS class II drugs. Poor water solubility may result in insufficient absorption and finally affects the bioavailability of the drug causes ineffectiveness in lowering lipid profile of patients. In recent years, solid dispersion technology has proved to be a simple, effective and economical approach for industrial application to increase the solubility of these drugs. This review paper is an attempt to compile up various research as well as patents reports related to solid dispersions of poor water soluble antihyperlipidemic drugs.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference117 articles.
1. Global Health Observatory data. World health Organization Updates. WHO updates; 2015. Available from: http://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/. [Last accessed on 28 Apr 2020]
2. Pan J, Ren Z, Li W, Wei Z, Rao H, Ren H. Prevalence of hyperlipidemia in shanxi province, china and application of bayesian networks to analyse its related factors. Sci Rep. 2018;8(1):3750. doi: 10.1038/s41598-018-22167-2, PMID 29491353.
3. Center of Disease Control and prevention. National Center for Health Statistics; 2018. Available from: http://www.cdc.gov/nchs/fastats/cholesterol.htm [Last accessed on 28 Apr 2020]
4. Gupta A, Sehgal V, Mehan S. Hyperlipidemia: an updated review. Int J Biopharm Toxicol Res. 2011;1(1):81-9.
5. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413-20. doi: 10.1023/a:1016212804288, PMID 7617530.